Chemical Profiling of Primary Mesothelioma Cultures Defines Subtypes with Different Expression Profiles and Clinical Responses von Schunselaar, Laurel M, Quispel-Janssen, Josine M M F, Kim, Yongsoo, Alifrangis, Constantine, Zwart, Wilbert, Baas, Paul, Neefjes, Jacques

Volltext

Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition von Quispel-Janssen, Josine M, Badhai, Jitendra, Schunselaar, Laurel, Price, Stacey, Brammeld, Jonathan, Iorio, Francesco, Kolluri, Krishna, Garnett, Matthew, Berns, Anton, Baas, Paul, McDermott, Ultan, Neefjes, Jacques, Alifrangis, Constantine

Volltext

Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial von Disselhorst, Maria J, Quispel-Janssen, Josine, Lalezari, Ferry, Monkhorst, Kim, de Vries, Jeltje F, van der Noort, Vincent, Harms, Emmy, Burgers, Sjaak, Baas, Paul

Volltext

Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma von Quispel-Janssen, Josine, van der Noort, Vincent, de Vries, Jeltje F., Zimmerman, Marion, Lalezari, Ferry, Thunnissen, Erik, Monkhorst, Kim, Schouten, Robert, Schunselaar, Laurel, Disselhorst, Maria, Klomp, Houke, Hartemink, Koen, Burgers, Sjaak, Buikhuisen, Wieneke, Baas, Paul

Volltext

Nose in malignant mesothelioma—Prediction of response to immune checkpoint inhibitor treatment von Disselhorst, Maria J., de Vries, Rianne, Quispel-Janssen, Josine, Wolf-Lansdorf, Marguerite, Sterk, Peter J., Baas, Paul

Volltext

Immune cells in mesothelioma microenvironment simplistic marker of response to nivolumab plus ipilimumab? von Disselhorst, Maria J., Lubeck, Yoni, van der Noort, Vincent, Quispel-Janssen, Josine, Seignette, Iris M., Sanders, Joyce, Peters, Dennis, Hooijberg, Erik, Baas, Paul

Volltext

OA13.01 A Phase II Study of Nivolumab in Malignant Pleural Mesothelioma (NivoMes): with Translational Research (TR) Biopies von Quispel-Janssen, Josine, Zago, Giulia, Schouten, Robert, Buikhuisen, Wieneke, Monkhorst, Kim, Thunissen, Eric, Baas, Paul

Volltext

High throughput therapeutic screening of malignant pleural mesothelioma (MPM) to identify correlation of sensitivity to FGFR inhibitors with BAP1 inactivation von Alifrangis, Constantine, Quispel Janssen, Josine, Badhai, Jitendra, Iorio, Francesco, Schunselaar, Laurel, Kolluri, Krishna, Baas, Paul, Garnett, Mathew, McDermott, Ultan

Volltext

Genomic characterization and high-throughput therapeutic screening of malignant mesothelioma to reveal novel tumor dependencies von Alifrangis, Constantine, Quispel Janssen, Josine, de Vries, Hilda, Schunselaar, Laurel, Bignell, Graham, Garnett, Mathew, Neefjes, Jacques, Berns, Anton, Baas, Paul, McDermott, Ultan

Volltext